New clinical studies surrounding the medication Retatrutide , specifically the high-dose formulation ZPHC ZPHC, reveal a impressive effect on weight reduction and linked chronic illnesses . Researchers posit that this dual agonist , targeting both GLP-1 and GIP systems, could represent a substantial improvement in the treatment of obesity and conn